PATENT CLAIM ANALYSIS

Application Number: 15874987
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "278000"]

Abstract:
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.

Claim (Index 6):
The compound of  claim 3  or a pharmaceutically acceptable salt thereof, wherein the compound is a compound of Formula 1-1, 1-2, or 1-3:

Metadata:
- Claim Count in Document: 59.0
- Percentile: 86.0
- Lexical Diversity: 1.52
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15221658', '15808242', '13215914', '14652150', '14902324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7798076828757636
- 35 USC 102 Novelty (BERT): 0.5732976540022336
- Combined Prediction Score: 0.7591566799884106
- Mean Citation Score: 367.432016
- Max Citation Score: 449.5534
- Similarity Product: 389.5955867743731

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test